Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU class 5 homeobox 1B (POU5F1B) is a protein-coding gene once considered a pseudogene, now shown to encode a protein highly homologous to the pluripotency factor OCT4. The protein is a weak transcriptional activator and is found predominantly in the cytoplasm and membranes, rather than the nucleus[2]. POU5F1B expression is low in normal tissues but highly upregulated in several cancers due to retroviral promoter or superenhancer activation. Its protein product fosters tumor growth, colony formation, angiogenesis, and metastatic potential, and serves as a strong negative prognostic biomarker in colorectal and other cancers[1][2][3]. Mechanistically, it activates intracellular signaling (e.g., AKT pathway) and may interact with membrane kinases and cytoskeletal elements[2][5]. Targeting POU5F1B is under investigation but not yet clinically established.
Gene/protein knockdown or inhibition leads to increased radiosensitivity and reduced proliferation (suggests potential utility for RNAi, CRISPR, or small molecule inhibition in cancer therapy). No approved drugs targeting POU5F1B yet.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU class 5 homeobox 1B (POU5F1B).